Although clinical immunity to malaria eventually develops among children living in endemic settings, the underlying immunologic mechanisms are not known. The Vd2 + subset of gd T cells have intrinsic reactivity to malaria antigens, can mediate killing of Plasmodium falciparum merozoites, and expand markedly in vivo after malaria infection in previously naïve hosts, but their role in mediating immunity in children repeatedly exposed to malaria is unclear. We evaluated gd T cell responses to malaria among 4-year-old children enrolled in a longitudinal study in Uganda. We found that repeated malaria was associated with reduced percentages of Vd2 + gd T cells in peripheral blood, decreased proliferation and cytokine production in response to malaria antigens, and increased expression of immunoregulatory genes. Further, loss and dysfunction of proinflammatory Vd2 + gd T cells were associated with a reduced likelihood of symptoms upon subsequent P. falciparum infection. Together, these results suggest that repeated malaria infection during childhood results in progressive loss and dysfunction of Vd2 + gd T cells that may facilitate immunological tolerance of the parasite.
INTRODUCTION
Children living in endemic settings eventually develop "clinical immunity" to malaria, characterized by a decline in symptomatic malaria episodes and an increasing proportion of Plasmodium falciparum infections that are asymptomatic. However, the immunologic mechanisms underlying the acquisition of clinical immunity are not known. Because most individuals fail to develop true sterilizing immunity (protection against parasitemia) and remain vulnerable to asymptomatic parasitemia into adulthood (1) , it has been suggested that clinical immunity may be due in part to immune tolerance of the parasite, rather than resulting entirely from an adaptive immune response that effectively protects against P. falciparum infection (2, 3) .
Several studies have shown that a subset of gd lymphocytes, Vg9 + Vd2 + T cells (also known as Vg2 + Vd2 + ), become rapidly activated upon stimulation with P. falciparum antigens during the blood stage of infection (4, 5) . These Vd2 + T cells react specifically to phosphoantigens produced by the plasmodial apicoplast and mediate killing of the invasive blood-stage merozoites via release of cytotoxic granules containing granulysin, a process that is T cell receptor-dependent but does not require processing or presentation by professional antigenpresenting cells (APCs) (6) (7) (8) . Vd2 + T cells have been shown to expand markedly in vivo after malaria infection in previously naïve hosts (9) (10) (11) , reaching percentages of up to 30% of circulating T cells (5) . After in vitro stimulation with P. falciparum-infected red blood cells (iRBCs), Vd2 + T cells produce interferon-g (IFN-g) and tumor necrosis factor-a (TNF-a) and proliferate vigorously (4, (12) (13) (14) (15) . These findings suggest that Vd2 + T cells may function as an innate-like immune response to malaria that may be important in control of P. falciparum infection.
Notably, most prior studies of antimalarial gd T cell function have been performed with cells obtained from malaria-naïve adults and individuals from low-exposure settings; few studies have explored the role of Vd2 + cells in the natural acquisition of immunity to malaria among children residing in highly endemic regions. Two small studies of individuals in malaria-endemic settings found no evidence of elevated gd T cell frequencies or in vivo expansion after malaria infection (16, 17) , raising the possibility that the antimalarial responsiveness of this population may be attenuated in the setting of chronic exposure. Further, although some have suggested that gd T cells play a beneficial role in protection from malaria (18) , other data suggest that production of proinflammatory cytokines by these cells may be implicated in the pathology of malaria (19, 20) . To better understand the role of gd T cells in the development of immunity to malaria, we examined a cohort of children in rural eastern Uganda with heavy yearround exposure to P. falciparum. We hypothesized that chronic and repeated malaria exposure may lead to down-regulation of the Vd2 + T cell response. Here, we show that Vd2 + cells decline in both number and function after repeated malaria exposure, and that loss of this proinflammatory response may be associated with clinical tolerance to malaria.
RESULTS

Study cohort and clinical outcomes
The study cohort consisted of 78 HIV-uninfected children enrolled before 1 year of age. Complete clinical histories, including documentation of all symptomatic malaria episodes and frequent screening for asymptomatic parasitemia, were available through 5 years of age. The incidence of symptomatic malaria in this cohort was high but variable [5.4 episodes per person-year (ppy); interquartile range, 3.2 to 7.0] and peaked at 25 months of age with a subsequent gradual decline in malaria episodes and a corresponding increase in asymptomatic parasitemia (Fig. 1 ). For this study, blood was drawn from all subjects at 4 years of age, and again at 5 years in a longitudinal subset, enabling assessment of gd T cell correlates of both prior malaria exposure and prospective protection. One child had symptomatic malaria (parasitemia with a fever requiring treatment) at the time of the 4-year blood draw, and 17 (22%) had blood smears demonstrating parasitemia.
Loss of Vd2
+ gd low cells in setting of heavy prior malaria We measured peripheral blood percentages of gd T cells from all subjects at 4 years of age and observed two distinct populations of gd T cells (gd high and gd low ) corresponding to the two major gd subsets: Vd1 + and Vd2 + (Fig. 2, A to C, and fig. S1 ). The majority of Vd2 + T cells expressed the Vg9 chain (median, 95%). We noted a marked inverse association between percentages of Vd2 + cells and the prior cumulative incidence of malaria (r s = -0.39, P = 0.003, Fig. 2D) . A similar relationship was observed between percentages of Vd2 + cells and the total number of prior parasitemic months (r s = -0.41, P = 0.002, n = 55). However, there was no significant relationship between Vd1 + T cell percentages (or total gd T cell percentages) and the prior incidence of malaria ( Fig. 2E and fig. S1 ). Despite prior studies describing rapid in vivo expansion and high circulating frequencies of Vd2 + cells after infection of malaria-naïve adults (9), we did not observe a significant relationship between Vd2 + T cell percentages and concurrent parasitemia, or duration since last malaria infection, among these chronically malaria-exposed children.
On the basis of these results, longitudinal measurements were performed at 5 years of age in a subset of children with particularly high or low malaria exposure between 4 and 5 years of age to test the hypothesis that repeated malaria episodes led to sustained and specific depletion of Vd2 + gd T cells from peripheral blood. Vd2 + cell percentages declined significantly among children with ≥8 intercurrent episodes of symptomatic malaria ppy, in contrast to stable or rising Vd2 + cell percentages among children with 0 to 1 intercurrent malaria episodes ppy (median fold change, 0.68 versus 1.27, respectively; P = 0.007; Fig.  2F and fig. S2 ). Together, these findings suggest that heavy malaria exposure results in the loss of Vd2 + gd T cells from peripheral blood.
Dysfunction of Vd2
+ gd low cells after repeated malaria infection We next investigated the functional responsiveness of gd T cells to malaria antigens and its relationship to prior malaria exposure. Prior studies have demonstrated robust proliferation and production of inflammatory cytokines in response to stimulation with malaria parasites among malaria-naïve individuals and those with low prior exposure (4, 9) , suggestive of an innate-like immune response. We observed that in vitro stimulation with P. falciparuminfected red blood cells resulted in robust, but variable, production of IFN-g and TNF, with a subset of these cells coproducing interleukin-2 (IL-2), but no appreciable production of IL-17 or IL-10 ( Fig. 3, A -"effector memory"-like gd T cells (21) , although expression of these memory markers did not significantly differ based on prior malaria exposure.
We found that the functional responsiveness of Vd2 + gd T cells to malaria declined in parallel with the quantitative decline in Vd2 + percentages. Malaria-specific production of inflammatory cytokines (IFN-g and TNF-a) by gd low cells was inversely associated with increasing prior malaria incidence (r s = -0.41, P = 0.0002, Fig. 3C ). A similar relationship was observed between percentages of cytokine-producing gd low cells and the total number of prior parasitemic months (r s = -0.43, P = 0.0001, n = 78). Concurrent parasitemia did not influence the percentage of IFN-g + or TNF + gd low cells (P = 0.69 and 0.89, respectively, Wilcoxon rank sum; n = 78). As an additional measure of Vd2 + gd T cell function, we assessed proliferation in response to malaria antigen stimulation in a CFSE dilution assay. Again, a strong inverse correlation was observed between Vd2 + T cell proliferation and cumulative prior malaria incidence (Fig. 3, D and E), suggesting that heavy malaria antigen exposure may result in a proliferative defect in Vd2 + T cells. Together, these results indicate that children who have survived repeated clinical malaria episodes exhibit dysfunction and loss of Vd2 + cells.
Increased expression of immunoregulatory pathways in Vd2 + T cells from heavily exposed children Considering the diminished malariaspecific responsiveness of Vd2 + T cells from children with numerous prior malaria episodes, we hypothesized that repeated infection may lead to the up-regulation of immunoregulatory pathways that dampen the innate Vd2 inflammatory response, as a means of evading host immunopathology. To test this hypothesis, we compared basal gene expression patterns of sorted, unstimulated Vd2 + T cells from children with high (≥8 ppy, n = 4) and low (<2 ppy, n = 4) prior malaria incidence using wholetranscriptome analysis. We identified 48 differentially expressed genes [false discovery rate (FDR) ≤0.05, fold change ≥2, Fig. 4A ], many with known roles in immunomodulation. For each of these genes, expression was higher among individuals with high prior exposure to malaria. These include HAVCR2, which encodes the receptor Tim-3 (T cell immunoglobulin and mucin domain-containing 3), a cell surface marker that has been implicated in tolerance and exhaustion of T helper 1 (T H 1) cells (22) (23) (24) (25) (26) ; FCRL6, which encodes the ITIM-containing Fc receptor-like protein 6 (27) ; LYN, which negatively regulates B cell receptor signaling through phosphorylation of ITIM-containing receptors (28); BATF, a transcription factor up-regulated in exhausted CD8 + T cells (29) ; and B3GAT1, which encodes CD57, a cell surface protein that has been associated with replicative senescence of CD8 + T cells in the setting of chronic antigen exposure (30) . Confirmatory analyses were performed by flow cytometry in children with high or low prior incidence, showing higher Tim-3, FCRL6, CD57, and CD16 on Vd2 + gd T cells from children with numerous prior malaria infections ( Fig. 4B and table S1).
We next compared induction of gene expression by sort-purified Vd2 + T cells after 4-hour in vitro stimulation with malaria-infected red blood cells. In children with <2 prior episodes ppy (n = 4), 171 genes were up-regulated after in vitro stimulation with iRBCs ( Fig. 5 , A and B). In contrast, only 17 of these genes were up-regulated in children with ≥8 episodes (n = 3; Fig. 5 , A and B, and table S2). Several of these differentially induced genes encode cytokines, including IFNG, IL2, IL3, IL4, CSF2 (encodes granulocyte-macrophage colonystimulating factor), and LTA (Fig. 5C ). In children with ≥8 prior episodes ppy, mRNA expression of these cytokine-encoding genes was significantly lower after in vitro stimulation in comparison to children with <2 prior episodes ppy (Fig. 5D ). Together, these data strongly suggest that chronic recurrent malaria infection leads to upregulation of immunoregulatory pathways that dampen the immune response. T cells. Shown is carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution after 7 days of P. falciparum stimulation in one representative sample from a child with low prior incidence (left) and one representative sample from a child with high prior incidence (right). (E) Vd2 + proliferation was assessed in a subset of children (n = 42) and found to be inversely associated with the prior incidence of malaria. Solid lines in (C) and (E) represent best-fit regression lines.
Loss and dysfunction of Vd2
+ T cells associated with clinical immunity to malaria Finally, we evaluated the relationship between the frequency and function of Vd2 + T cells and protection from symptomatic malaria, as assessed during 1 year of prospective observation (ages 4 to 5 years). Percentages of malaria-responsive gd low T cells were significantly lower in children who experienced at least one episode of asymptomatic infection in the year of follow-up compared to children who developed fever with each subsequent malaria infection (P = 0.008, Fig. 6 ). Although children with lower percentages of cytokine-producing gd low T cells had a higher risk of parasitemia throughout the study (Fig. 7A) , these highly exposed children had a significantly lower probability of exhibiting symptoms if they became parasitemic during the year of follow-up [odds ratio (OR), 0.27; P = 0.036; Fig. 7B ]. This reduced risk of symptoms remained significant after adjusting the analysis for prior or current malaria exposure (OR, 0.14; 95% confidence interval, 0.04 to 0.5; P = 0.0025). Furthermore, children in the lowest tertile of malariaresponsive gd low T cell responses experienced a significant decline in their overall incidence of symptomatic malaria in the year of follow-up, whereas children in the highest tertile did not experience a decline in the incidence of symptomatic malaria (Fig. 7C) . Together, these findings suggest that gd T cells do not protect against P. falciparum infection, but that with progressive loss of malaria-responsive Vd2 + gd low T cells, there is an increased likelihood that infections will be asymptomatic, consistent with the development of immunologic tolerance to malaria parasites.
DISCUSSION
Our results demonstrate that, in contrast to the expansion of Vd2 + cells after malaria infection of previously naïve individuals (9-11), repeated malaria exposure is associated with reduced percentages of Vd2 + gd T cells in peripheral blood, decreased proliferation and cytokine production in response to malaria antigens, and increased expression of immunoregulatory genes. Further, in this cohort, loss and dysfunction of proinflammatory Vd2 + gd T cells were associated with a reduced likelihood of symptoms upon subsequent P. falciparum infection. These findings support the hypothesis that the clinical immunity to malaria observed in young children living in endemic regions may not be mediated entirely by an adaptive immune response to the parasite, but rather, at least in part, by attenuation of the proinflammatory response of semi-innate gd T cells, resulting in tolerance of P. falciparum infection, a hypothesis forwarded in the early 1990s by Goodier et al. (17) .
Our results are consistent with several recent studies indicating that malaria infection results in attenuation of proinflammatory responses, as well as dysfunction and/or exhaustion of numerous immune cell subsets, including ab T cells (31) (32) (33) (34) (35) , B cells (31, 36) , and myeloid cells (37) . Portugal et al. recently demonstrated a decrease in iRBC-stimulated expression of genes encoding proinflammatory cytokines and chemokines in children after their first malaria infection of the season (3, 19) . Because these analyses were performed on bulk unfractionated peripheral blood mononuclear cells (PBMCs), the cellular subsets responsible for this blunted inflammatory response were not identified. We KIR2DS2  LOC100287482  LYN  MELK  MTSS1  NMUR1  PARD6G  PATL2  PDGFD  PLCG2  PRSS23  RHOBTB3  RNF135  SLCO4C1  SUSD1  TRIO  TXNDC3  TXNIP  VAV3  XLOC_001625  ZNF658 Log 2 relative expression + gd T cells from children with <2 episodes ppy versus ≥8 episodes ppy (n = 4 per group). Differentially expressed genes (determined using a 5% FDR, fold change ≥2 with two-class unpaired comparisons) are depicted as a heat map of relative expression intensities, log 2 -normalized to the median expression across all samples for each gene. Yellow represents higher and blue represents lower expression relative to the median; gene names depicted in red represent genes with previously reported roles in tolerance or immunoregulation, with common protein names provided in parentheses following the official gene symbol. (B) Flow cytometric analyses confirming increased expression of immunoregulatory proteins in children with high prior malaria incidence (n = 4 to 5 per group, Wilcoxon rank sum; see table S1 for individual data).
have previously shown, in the same cohort of children described here, that repeated malaria infection leads to a decline in the frequency of TNF-producing CD4 + T cells and an expansion of malariaspecific, autoregulating T H 1 CD4 + cells that coproduce IFN-g along with IL-10, an anti-inflammatory cytokine (38) . Frequencies of IL-10-producing CD4 + T cells were higher in children with current or recent parasitemia (3, 38), but were not associated with prospective protection from malaria or with a reduced likelihood of symptoms upon reinfection (38) . Thus, although several lines of evidence suggest that T cell production of proinflammatory cytokines may decrease with prior malaria exposure, these prior studies were not able to demonstrate a relationship with prospective clinical outcomes such as febrile malaria, as we have shown here for Vd2 + T cells. In mice, malaria infection leads to up-regulation of the T cell inhibitory receptors PD1 and LAG-3 on T cells, resulting in T cell "exhaustion," which contributes to an inability to clear the infection (32, 34) . Up-regulation of PD1 and LAG-3 on CD4 + T cells has also been reported in children chronically exposed to malaria (31, 32) . However, PD1 and LAG-3 were not differentially expressed by Vd2 + T cells from high-and low-exposure children in our cohort. Rather, we found that Vd2 + gd T cells up-regulate alternate immunomodulatory pathways, such as Tim-3. The fact that gd T cells use distinct immunomodulatory pathways (compared to conventional ab T cells) is perhaps not surprising given the semi-innate role of gd T cells and their frequent coexpression of surface markers conventionally associated with natural killer cells. In light of our novel observation that loss and dysfunction of Vd2 + cells are associated with a reduced likelihood of symptoms upon subsequent P. falciparum infection, such pathways may represent important mechanisms by which repeated malaria infection leads to blunted inflammatory responses by Vd2 + T cells. Because sampling for most assays was performed at a single time point, unmeasured confounders, including genetic, environmental, or other immunologic factors, limit our ability to infer causality from these observations. Nonetheless, the sustained and progressive decline in Vd2 + T cells observed in children with numerous intercurrent malaria episodes, in contrast to stable to rising percentages in those with few or no episodes, strongly support our conclusion that repeated malaria exposure is associated with a loss of Vd2 + gd T cells. Although the loss and dysfunction of Vd2 + T cells were statistically associated with the development of asymptomatic infection, it remains to be shown that this cell subset is causally responsible for reduced symptomatology; many immune effector populations are regulated in concert, any of which may contribute to the clinical symptoms (or lack of symptoms) of malaria. Larger prospective studies incorporating longitudinal measurements, as well as careful prospective measures of malaria incidence and exposure, will be needed to further elucidate the relationship between P. falciparum exposure, gd T cell function, and clinical immunity to malaria.
Given the intrinsic reactivity of Vg9 + Vd2 + T cells to P. falciparum and their direct anti-merozoite effects in vitro (4) (5) (6) 8) , it is likely that these cells may play a beneficial role as ready-made effectors during primary acute malaria infection of infants (39) . However, our data suggest that they do not protect against reinfection or parasitemia, at least -producing gd low T cells had a consistently higher monthly probability of parasitemia (A), but lower probability of symptoms if parasitemic (B). Although children in the lowest tertile had a higher incidence of symptomatic malaria early in the study (C), by 48 to 60 months of age, the incidence of symptomatic malaria in the two groups was similar. (D) Associations between the lowest versus highest (reference group) of gd T cell responses and the monthly risk of parasitemia, probability of developing symptoms if parasitemic, and incidence of malaria, stratified by year of age using generalized estimating equations with robust SEs.
in the young children living in this high transmission setting. Although the progressive loss and dysfunction of Vd2 + gd T cells are associated with reduced symptoms, it may conceivably interfere with effective clearance of the infection, allowing persistence of parasitemia and propagation of P. falciparum to the next host. These findings have important implications in understanding the immunopathogenesis of malaria in childhood and suggest a mechanism of clinical immunity to repeated malaria infection in high incidence settings.
MATERIALS AND METHODS
Ethical approval
Informed consent was obtained from the parent or guardian of all study participants. The study protocol was approved by the Uganda National Council of Science and Technology and the institutional review boards of the University of California, San Francisco (UCSF), Makerere University, and the Centers for Disease Control and Prevention.
Study site, participants, and clinical outcomes Samples for this study were obtained from a subset of children enrolled in the Tororo Child Cohort (TCC) in Tororo, Uganda, a rural district in southeastern Uganda with an entomological inoculation rate estimated at 310 infective bites ppy (40) . Details of the larger TCC study and eligibility criteria used for enrollment have been previously described (41, 42) . The subjects in this report only include children who were born to HIV-uninfected mothers, further described in (43) , and included all children who were still enrolled in the study at the time of blood sampling at 4 years of age (n = 78). Briefly, children were enrolled in infancy (median, 5.5 months of age) from the postnatal clinic at Tororo District Hospital, and were eligible for enrollment if they lived within a 30-km radius of the study clinic and agreed to come to the study clinic for all medical care. Children were followed for all medical problems at a dedicated study clinic, with monthly assessments to perform routine blood smears and ensure compliance with study protocols. Children who presented with a documented fever (≥38.0°C) or history of fever in the previous 24 hours had blood obtained by finger prick for a thick smear. If the thick smear was positive for malaria parasites, then the patient was diagnosed with malaria and given artemisinin-based combination therapy. At the time of their first episode of uncomplicated malaria, study participants were randomly assigned to receive open-label artemether-lumefantrine (AL) or dihydroartemisinin-piperaquine (DP). Study participants received the assigned treatment for all subsequent episodes of uncomplicated malaria. Both treatments were shown to be efficacious for treatment of malaria infection (41); treatment with DP was associated with a 15% less risk of malaria over the 5-year period of the study, because of a delayed time to recurrent malaria (42) . Children with asymptomatic parasitemia were not provided antimalarial therapy, in accord with local guidelines.
Incident episodes of malaria were defined as all febrile episodes accompanied by any parasitemia requiring treatment, but not preceded by another treatment in the prior 14 days (43). The incidence of malaria was calculated as the number of episodes ppy at risk, with prior cumulative incidence defined as the incidence ppy from study enrolment until the time of the blood draw. Asymptomatic parasitemia was defined as a positive routine blood smear in the absence of fever that was not followed by the diagnosis of malaria in the subsequent 7 days. The number of parasitemic months was calculated from routine monthly blood smears, regardless of the presence or absence of symptoms. The conditional probability of developing malaria once parasitemic was calculated as a binary outcome (malaria or asymptomatic parasitemia, as defined above) and assessed at monthly intervals, in accordance with published methods (44) .
Sample collection and processing At 4 years of age, 6 to 10 ml of whole blood was obtained from each subject in acid citrate dextrose tubes. In a subset of children (n = 12), whole blood was also obtained at 5 years of age. PBMCs were isolated by density gradient centrifugation (Ficoll-Histopaque; GE Life Sciences). PBMCs were cryopreserved in liquid nitrogen and shipped to our laboratory in San Francisco for evaluation. Analysis of cell viability using Guava ViaCount (Millipore) consistently demonstrated >80% viability after thaw.
Malaria antigens P. falciparum blood-stage 3D7 parasites were grown by standard methods and harvested at 5 to 10% parasitemia. Red blood cells infected with mature asexual stages (iRBCs) were purified magnetically, washed, and cryopreserved in glycerolyte before use as previously described (38) . Uninfected RBCs (uRBCs) were used as controls. P. falciparum schizont extracts (PfSE) for use in proliferation experiments were prepared by three freeze-thaw cycles of iRBCs in liquid N 2 for freezing and 37°C water bath for thawing, then resuspended in R10 medium, and stored at -20°C until use.
Intracellular cytokine staining
Thawed PBMCs were rested overnight in 10% fetal bovine serum (Gibco) and counted before stimulation with uRBCs, iRBCs, media, or phorbol 12-myristate 13-acetate/calcium ionophore at 1 × 10 6 cells per condition. An effector-to-target (E:T) ratio of 1:3 was used with uRBCs and iRBCs. Anti-CD28 and anti-CD49d were added for costimulation (0.5 mg/ml, BD Pharmingen). Brefeldin A and monensin (BD Pharmingen) were added at 6 hours of incubation at a final concentration of 10 mg/ml to inhibit cytokine secretion. At 24 hours of incubation, cells were washed, fixed, and permeabilized per standard protocols (Invitrogen/Caltag).
Surface and/or intracellular staining of PBMCs was done with standard protocols using the following antibodies for the primary analysis: Brilliant Violet 650-conjugated CD4, allophycocyanin (APC) anti-gd (clone B1), Brilliant Violet 421-conjugated anti-IL-2 (BioLegend), peridinin chlorophyll protein (PerCP)-conjugated anti-CD3, APC-H7-conjugated CD8, phycoerythrin (PE)-Cy7-conjugated IFN-g, PE-conjugated anti-IL-10, and fluorescein isothiocyanate (FITC)-conjugated TNF-a (BD Pharmingen). Alexa Fluor 700-conjugated CD14 and CD19 and LIVE/DEAD aqua amine (Invitrogen) were included as exclusion gates to reduce unwanted nonspecific antibody binding when measuring antigen-specific T cell populations. Additional experiments used PEconjugated Vd2, FITC-conjugated Vd1, Brilliant Violet 605-conjugated CD45RA, FITC-conjugated CCR7, PE-conjugated FCRL6, FITCconjugated CD57, Pacific Blue-conjugated CD16 (BioLegend), and PE-conjugated Tim-3 (R&D).
CFSE proliferation assay
Thawed PBMCs were rested for 1 hour and washed in 10% Human AB medium (Gemini), and 3 × 10 6 to 6 × 10 6 PBMCs were labeled with 1 ml of 1.25 mM CFSE (Molecular Probes) for 7 min. CFSE-labeled PBMCs were incubated in 96-well, deep-well culture plates (Nunc) at a density of 10 6 PBMCs per well at a final volume of 1 ml for 7 days. Antigens tested included media, phytohemagglutinin (5 mg/ml; Sigma-Aldrich), uRBCs, or PfSE at an E:T ratio of 1:3 schizont equivalents. At day 7, cells were treated with 100 U of deoxyribonuclease I (Invitrogen) in culture medium at 37°C for 10 min, washed, and stained with surface antibodies [PerCP-conjugated anti-CD3, APC-H7-conjugated CD8 (BD Pharmingen), Brilliant Violet 650-conjugated CD4, Alexa Fluor 700-conjugated CD14 and CD19, PE-conjugated anti-Vd2, and APC-conjugated anti-gd (BioLegend)] before acquisition.
Cell sorting
Thawed PBMCs were rested overnight and left unstimulated or stimulated with iRBCs for 4 hours. Cells were promptly stained for cell surface markers, and ∼1 × 10 4 to 3 × 10 4 cells (>99% pure) were double-sorted directly into RNA lysis buffer (Ambion) with a FACSAria (BD) and stored at -80°C until RNA amplification.
Flow cytometry data analysis
Flow cytometry profiles were gated on CD3 + lymphocytes, and 200,000 to 300,000 events were collected ( fig. S2 ). Samples were analyzed on an LSR2 three-laser flow cytometer (Becton Dickinson) with FACSDiva software. Color compensations were performed for each patient's PBMCs using beads or samples single-stained for each of the fluorochromes used. Data were analyzed using FlowJo (Tree Star) and Pestle (version 1. Whole-transcriptome microarray analysis RNA was isolated using an RNAqueous-Micro kit (Life Technologies) and amplified in two rounds using the Amino Allyl MessageAmp II kit (Life Technologies). Amplified RNA was covalently coupled to Cy3 and hybridized to SurePrint G3 Human Gene Expression 8x60K v2 gene expression microarrays (Agilent) according to the manufacturer's protocol. Arrays were scanned on an Agilent microarray scanner, and raw signal intensities were extracted with Agilent Feature Extraction software.
Raw intensities for 58,717 features represented on the microarray were log 2 -transformed and quantile-normalized using the R package limma (45) . Unexpressed probes (38, 511) were removed from the data set, with expression being defined as a probe having a log 2 -normalized intensity of greater than 7 for all samples within at least one sample group. Expression values for each probe were centered to the median across samples to enhance between-sample differences when visualized as heat maps (relative yellow to blue). Differentially expressed genes were identified using Significance Analysis of Microarrays. For comparisons of unstimulated samples between low and high prior incidence groups, two-class unpaired comparisons were performed. For comparisons of iRBC-stimulated versus unstimulated samples, paired comparisons were performed. The fold change after stimulation was calculated as the difference in the means of log 2 gene expression between stimulated and unstimulated samples. A 5% FDR and twofold change cutoff were observed to identify differentially expressed genes (46) .
STATISTICAL METHODS
All statistical analyses were performed using Prism 4.0 (GraphPad), STATA version 12 (College Station), SPICE v.5.3 [National Institute of Allergy and Infectious Diseases (NIAID)], or R version 3.0.2. We first examined associations between immunologic outcomes with exposure variables including prior cumulative incidence, concurrent parasitemia at the time of the assay, and antimalarial treatment allocation. Comparisons of cellular percentages between groups were performed using the Wilcoxon rank sum and/or t test, and the Wilcoxon signedrank and/or paired t test was used to compare paired data. Associations between continuous variables were assessed using Spearman's rank correlation (r s ). Concurrent parasitemia and antimalarial treatment assignment did not significantly alter the immunologic assessments reported in this study.
Associations between the absence or presence of any asymptomatic infection during the year of follow-up and percentages of cytokineproducing gd T cells were made using the Wilcoxon rank sum test, and were conditional on the presence of any parasitemia during this period. Forty-four of 47 children with asymptomatic infection during follow-up also had at least one symptomatic infection. Generalized additive models with smoothing splines were used to visualize the effects of age and gd T cell responses on the monthly risk of parasitemia, probability of symptoms if parasitemic, and incidence of malaria (47) . Associations between the highest and lowest tertiles of gd T cell responses and the monthly risk of parasitemia, probability of symptoms if parasitemic, and incidence of malaria, stratified by year of age, were evaluated using generalized estimating equations with robust SEs accounting for repeated measures in the same patient (48) . Multivariate models assessing the probability of symptoms if infected in the year after the assay included antimalarial treatment allocation, presence or absence of concurrent parasitemia, and prior malaria exposure, defined as total months with parasite infection. Two-sided P values were calculated for all test statistics, and P < 0.05 was considered significant.
SUPPLEMENTARY MATERIALS
www.sciencetranslationalmedicine.org/cgi/content/full/6/251/251ra117/DC1 Fig. S1 . Gating strategy and relationship of gd T cell subsets with prior malaria. Fig. S2 . Longitudinal measurements of Vd2 + gd T cells at 4 and 5 years of age in a subset of children with high or low malaria exposure. Table S1 . Flow cytometric expression of immunoregulatory proteins identified by wholetranscriptome analysis. Table S2 . Microarray-based gene expression fold change analysis of in vitro-stimulated purified Vd2 + T cells.
